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ABSTRACT

Since the year 2000, the Defense and Veterans Brain Injury Center reported 414,000
documented cases of traumatic brain injuries (TBIs) among individuals serving in the United
States Armed Forces (Defense and Veterans Brain Injury Center, 2020). Traumatic events to the
head as a result from car accidents, falls, explosions, and gunshot wounds can lead to a
disruption of normal cognitive functioning. Roughly 80% of diagnosed TBIs are mild in nature,
commonly referred to as concussions, and can range from mild, moderate, severe, and
penetrating (O’Neil et al., 2013). However due to the difficulty of diagnosing a TBI most cases
go undocumented, or patients do not seek treatment. TBIs that are left untreated can result in
progressive neurostructural damage which can lead to the development of dementia-related
diseases as well as psychological problems such as post-traumatic stress disorder (PTSD)
(McKee et al., 2014). The physical and mental health conditions that can result from sustaining a
TBI can drastically impact the lives and families of those injured veterans. With an estimated 8
million adults suffering from PTSD each year as per the National Center for PTSD (2020),
researchers must understand how to utilize the linkage between a TBI and PTSD in order to
appropriately prevent progressive neurodegeneration and any associated psychological problems
(Gradus, 2019).
Previous studies have shown evidence that both single-incidence and repetitive mild TBIs
(mTBIs) can lead to atrophy of the grey and white matter in the brain and can promote the
acceleration of neurodegeneration in the brain (Gradus, 2019).This chronic neurodegeneration
can pose an increased risk for the development of progressive neurodegenerative diseases such
as Parkinson’s Disease, Alzheimer’s Disease, Frontotemporal Lobar Degeneration (FTLD), and
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Chronic Traumatic Encephalopathy (CTE) (Gradus, 2019; National Center for PTSD, 2020).
Accompanying neurodegeneration are behavioral changes, executive dysfunction, memory loss,
and cognitive impairments (DePalma et al., 2018). Researchers have begun to find associations
between PTSD and TBI as a result of the disruptions to certain neuropathways from the
amygdala and orbitofrontal cortex (DePalma et al., 2018; McKee et al., 2014). This capstone
project is a literature review of the neurostructural and cognitive-behavioral changes that result
from traumatic brain injuries. The research provided in this paper explores the connections
between neurostructural damage and progressive neurodegenerative diseases such as
Alzheimer’s Disease (AD), FTLD, and CTE. Psychological effects that stem from sustaining a
TBI including post-traumatic stress disorder (PTSD) and the increased risk for suicide and selfharm are also discussed.
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INTRODUCTION
Traumatic Brain Injury
The Defense and Veterans Brain Injury Center (DVBIC) defines a traumatic brain injury
(TBI) as a “blow or jolt to the head that disrupts normal functioning of the brain” (Defense and
Veterans Brain Injury Center, 2020). Car accidents, falls, explosions, and gunshot wounds are all
common traumatic events that can lead to an individual, whether civilian or soldier, sustaining a
TBI. Sustaining an TBI while serving in the military is unpredictable and spontaneous, yet blast
exposures from bombs, grenades, and improvised explosive devices (IEDs) remain the most
common cause of TBIs sustained in combat (McKee et al., 2014). One group of researchers
found that in U.S. troops deployed to Iraq and Afghanistan during Operation Iraqi Freedom
(OIF), Operation Enduring Freedom (OEF), and Operation New Dawn (OND), the occurrence of
blast related TBIs varied from 15-23%, affecting almost 400,000 troops (McKee et al., 2014;
Rosenfeld et al., 2013). Additionally, another group of researchers screened 1 million veterans of
the 2.6 million serving from 2007 through 2015. Roughly 20% of the 1 million veterans screened
positive on questions pertaining to TBI-sustaining events, immediate symptoms, new or
worsening symptoms, and current symptoms. Of the positively screened veterans, almost 10%
were positive for a concussion/mild TBI. When these results are compared to the civilian world,
the prevalence among civilians is greatly decreased. In a survey of 57,392 civilian trauma cases
in the United States, 89 (0.2%) where blast-related injuries, demonstrating how rare traumatic
brain injuries are to the general population (Elder et al., 2010). The increasing prevalence of
TBIs in combat situations requires an immediate concussive assessment in order to prevent and
limit the number of exposures to traumatic events. While the assessments in place are able to flag
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soldiers for possible concussive events, many do not self-report the incidences thus leading to
difficult diagnoses.

BACKGROUND
TBIs remain one of the most difficult brain injuries to diagnosis correctly among soldiers
and it is one of the least understood in terms of the disrupted mechanisms and pathways (McKee
et al., 2014). U.S. soldiers can experience reoccurring and progressive long-term effects after
sustaining a TBI, with resulting cognitive, behavioral, and physiological changes. Common selfreported symptoms by U.S. soldiers include headaches, cognitive dysfunctions, attention
difficulties, and impaired balance, and all will vary with the severity of the sustained TBI. TBI is
considered one of the “invisible” wounds sustained during military service due to the lack of
external evidence for head or brain injuries. Until imaging and questionaries are obtained
through a medical care provider can a TBI diagnosis be given. Diagnosed traumatic brain
injuries are classified on a scale of mild, moderate, and severe. The Department of Defense
(DOD) and the Department of Veteran Affairs (VA) use 6 criteria in their diagnosis of a TBI, as
shown in Table 1: structural imaging, loss of consciousness (LOC), alteration of consciousness
(AOC), post-traumatic amnesia (PTA), and the Glasgow Coma Scale (GCS) (shown in Table 2).
(O’Neil et al., 2013; Rosenfeld et al., 2013).

Table 1.

Classification of TBI severity
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BEHAVIOR

RESPONSE

Spontaneously
To speech
To pain
None
Oriented
Best Verbal Response
Confused
Inappropriate
Incomprehensible
None
Obeying
Best Motor Response
Localizing
Withdrawal
Flexing
Extending
None
Table 2. Glasgow Coma Scale (recreated using CDC guidelines)
Eye Opening Response

SCORE
4
3
2
1
5
4
3
2
1
6
5
4
3
2
1

A mild TBI (mTBI) is defined as having normal structural imaging, LOC lasting less than
30 minutes, AOC lasting less than 24 hrs, PTA lasting less than 1 day, and a GCS score of 13 to
15. A moderate TBI is defined as having normal or slightly abnormal structural imaging, LOC
lasting 30 mins up to 24 hrs, AOC lasting at least 24h hrs, PTA lasting from 1 day to 1 week, and
a GCS score of 9 to 12. A severe TBI is defined as having normal or abnormal structural
imaging, LOC lasting more than 24 hrs, AOC lasting more than 24 hrs, PTA lasting at least 1
week, and a GCS score less than 9. While a clinical diagnosis exists, TBIs remain one of the
most difficult brain injuries to diagnosis correctly among soldiers and the acute and long-term
effects have been a poorly researched and explored (McKee et al., 2014). U.S. soldiers can
experience persistent and progressive long-term effects after sustaining a TBI, with resulting
cognitive, behavioral, and physical changes. Commonly self-reported symptoms by U.S. combat
veterans include headaches, forgetfulness, poor concentration, and anxiety. These symptoms
typically self-resolve over the course of a few days to weeks, however 10-20% of soldiers report
continued unresolved problems (Vasterling et al., 2009). These cognitive dysfunctions, attention
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difficulties, impaired balance, and physiological changes all will vary with the severity and
classification of TBI.
Although most neurological symptoms are subjective in nature due to veterans selfreporting to their primary care physicians, there are two initial assessments used to for any
suspected TBIs. The Military Acute Concussion Evaluation (MACE) is an initial mental status
assessment given to veterans who may or may not have been involved in an acute concussive
event (Air Force Center of Excellence for Medical Multimedia). The assessment contains 4
sections: a concussion screening, a cognitive exam, a neurological exam, and a symptom
screening. The initial concussion screening looks to identify information about the sustained
concussive event, whether there was loss of consciousness, alteration of consciousness, and/or
post-traumatic amnesia. The cognitive exam focuses on orientation, memory, and recall of the
veteran post concussive event. The neurological exam tests for pupil responses to light, speech
ability and comprehension, grip strength, and balance. The last section involves symptom
screening, which screens veterans for the common complaints of headaches, dizziness, impaired
memory, balance problems, nausea/vomiting, tinnitus, and concentration. MACE should be the
initial assessment given to any U.S. soldier who has experienced a concussive event within the
first 24 hours of the event happening. For those combat veterans who are experiencing symptoms
past that window of time or those who have screened positive on the MACE, they are given the
Comprehensive Traumatic Brain Injury Evaluation (CTBIE) through the VHA healthcare
system. The CTBIE is conducted by a TBI specialist who gathers an in-depth history of the
patient’s symptoms, the concussive event, review of body systems, physical exam, and
administers the Neurobehavioral Symptom Inventory (NSI). A formal diagnosis can be made,
and a treatment plan can be implemented based on the conclusive findings (Scholten et al.,
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2016). Treatment options and TBI management will be discussed later in the Discussion portion
of this paper.
As mentioned previously, blast related TBIs are the leading cause of traumatic brain
injuries among U.S. combat veterans, with blast-related mTBIs as the most common form
affecting military personnel (McKee et al., 2014). McKee et al. (2014) reports that 60% of TBIs
in the combat setting were of blast-related origin, with over 80% of those blast-related incidences
resulting in a mTBI diagnosis. A mild TBI (mTBI), commonly referred to as an acute injury or
simply a concussion, is typically caused by an impactful force, either directly or indirectly, to the
head, face, and/or neck region. A blast related TBI is broken down into four components:
primary, secondary, tertiary, and quaternary (Rosenfeld et al., 2013). Primary is characterized by
the initial transmission of the blast wave through the skull into the brain. Secondary refers to any
projectiles penetrating through the skull into the brain such as shrapnel or bullets. Tertiary is any
acceleration, deceleration, or rotational effects on the brain. Quaternary involves other injuries to
the head, face, neck and respiratory system such as any chemical or thermal injuries. The
primary component of a blast related TBI is involved with all severities of a TBI: mild,
moderate, and/or severe. Secondary, tertiary, and quaternary components are associated with
only moderate and severe TBIs. Blast related TBIs result in the transmission of acoustic waves
through the brain tissue. The blast waves can induce the brain tissue and surrounding blood
vessels to expand and contract, resulting in tears and breakage. These tears and damages can lead
to cerebral edema, intraparenchymal and subarachnoid hemorrhages, delayed vasospasms,
cerebral ischemia, herniations, and aneurysms (McKee et al., 2014; Rosenfeld et al., 2013).
Moderate and severe TBIs can also result in damages and eventual atrophy of the grey and white
matter in the brain as well as altered glucose metabolism (McKee et al., 2014; Petrie et al.,
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2014). Diffuse axonal injuries associated with moderate and severe TBIs cause the brain to
elongate and misshape due to rapid acceleration, deceleration, and rotational forces from a blast.
Axons that make up the neural circuitry in the brain are extremely susceptible to injury and
damage, so when the brain elongates and misshapes as a result of the blast, axons become
damaged. These microstructural changes in the white and grey matter and fiber tracts can result
in severe neurological and physiological changes. The microvasculature system is compromised
which leads to a disruption in the blood-brain barrier as well as focal cortical hypoperfusion
(McKee et al., 2014). Additionally, there is a rapid uncontrolled release of neurotransmitters
such as glutamate, changes within the sodium (Na+) channels and sodium-potassium (Na+/K+)
pumps, massive influx of calcium (Ca2+) ions, efflux of potassium (K+) ions, and an increase in
glucose metabolism (McKee et al., 2014).
The most widely used diagnostic definition of a TBI, taken from the Department of
Defense and Department of Veterans Affairs, states that normal structural imaging on CT and
MRI scans may or may not be present based on the severity of the TBI. Mild TBIs and some
moderate TBIs typically do not show any abnormalities on imaging scans, while severe TBIs
may show abnormalities. CT scans are the preferred choice during the first 24 hours after
sustaining a traumatic brain event. CT scans are able to detect any early bleeds and any cerebral
or bony pathology (Lee & Newberg, 2005). However, after 24 hours MRI scans are the preferred
choice as they are able to detect any hematomas, axonal injuries, or small neuronal damage (Lee
& Newberg, 2005). The pathophysiology of any blast related TBI is distinctive and varies across
individuals depending on the blast energy, distance from the initial blast, body orientation, use of
armor protection, the environment, and the frequency of blasts (Rosenfeld et al., 2013). All of
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these blast related effects play an important role in the pathological presentation of each TBI for
each individual veteran.
As mentioned above in the TBI diagnosis, most patients present with normal structural
imaging after sustaining a TBI. The use of MRI to detect any brain abnormalities has been
proven unreliable within the first 24 hours due to scans showing the absence of abnormalities
when in fact there may be some present (MacDonald et al., 2011). When T2 MRI scans do show
abnormalities, common findings include cerebral microhemorrhages, contusions, gliosis, and
encephalomalacia (Riedy et al., 2016). However, the common presentation of no visible damage
from CT or MRI scans does not mean there is an absence of any abnormalities (Elder et al.,
2010). Additional scans and tests must be done in order to determine the extent of the brain
injury. Diffusion tensor imaging studies have shown that soldiers who have sustained a TBI or
currently experience PTSD have disrupted white matter integrity (Davenport et al., 2015).
Diffusion tensor imaging (DTI) has become a widely popular diagnostic tool to determine the
severity of neuronal damage. DTI is a type of magnetic resonance imaging (MRI) that is
extremely sensitive to the diffusion rate of water in brain cells and tissue, measuring the
structural integrity of the surrounding white matter (Taber et al., 2015). Water diffuses through
grey matter at similar rates in every direction yet will diffuse differently through white matter
depending on the surrounding structure. The direction of water diffusion within the white matter
is controlled and bound by certain physical boundaries such as myelin and axon membranes
(Chanraund et al., 2010). This causes the water to diffuse more easily down the controlled
direction of the axon compared to perpendicularly, making the diffusion highly angiotrophic.
Thus, when there are structural and integrity changes within the white matter, the rate of
diffusion through the white matter will be uncontrolled and multidirectional, creating low
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anisotropy. This allows researchers to pinpoint and detect any subtle neurostructural changes
within the white matter and fiber tracts. Neuroanatomy changes as a result of TBIs have been
found in the cingulum, uncinate fasciculus, anterior and posterior limbs of the internal capsule,
cerebellar peduncles, and the genu of the corpus callosum (Petrie et al., 2014).
Another useful tool that has been proven to detect changes within the neuronal axons is
amyloid precursor protein immunohistochemistry (McKee & Robinson, 2014). This type of test
uses amyloid precursor proteins to visualize traumatic axonal injuries (TAIs) around small blood
vessels in the corpus callosum, fornix, subcortical U-fibers, and the cerebellum. This test looks
for accumulations of hyperphosphorylated tau (p-tau) in the form of neurofibrillary tangles
(NFTs) and hemosiderin-laden macrophages (McKee & Robinson, 2014). Researchers have
specifically linked these NFTs and hemosiderin-laden macrophages to axonal injuries, breaches
of the blood-brain barrier, and neuroinflammation, which are all extremely important
determiners for soldiers sustaining a TBI.
Neuroanatomy and Neural Pathways
Blast-related TBIs, whether mild, moderate, or severe, all can change the composition of
the neuroanatomy in the brain. The cerebrum, amygdala, hippocampus, orbitofrontal cortex,
frontal lobe, and temporal lobe, to name a few, are all heavily impacted as a result of sustaining a
traumatic brain injury. Injury to these structures can lead to downstream effects causing memory
problems, cognitive defects, behavioral abnormalities, and neuronal damage. The neuronal
pathways and connections that allow humans to function as their baseline “normal” become
disrupted. The limbic system is the epicenter for memory and emotion processing. The structures
that comprise the limbic system provide the link between our emotions and our drive-related
behaviors, as well as memory tasks and our reactions to sensory and internal stimuli (Felten &
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Shetty, 2005; Vanderah & Nolte, 2018). It is a grey area in terms of the structures and boundaries
within the limbic system, which include the cingulate gyrus, hippocampus, amygdala, septal
nuclei, hypothalamus, and olfactory bulbs. While all of these structures are vulnerable to
damage, the important TBI-related neuroanatomy includes the amygdala and hippocampus.
The amygdala is the control center for emotional responses, especially fear. Two kinds of
sensory inputs project to the amygdala for processing and responses: general senses (such as
taste, touch, smell, visual, and sounds) and physical and emotional senses. These inputs into the
amygdala are then processed and projected outward to other surrounding structures such as the
hypothalamus, septal nuclei, hippocampus, olfactory regions, basal ganglia, and other cerebral
cortical structures. These projections allow the amygdala to bridge the connections between the
“perception of objects and situations with the appropriate emotional response” (Vanderah &
Nolte, 2018). Typically, these emotional responses relate to fear or danger, but that is not always
the case. Projections from the thalamus allow the amygdala to process things in the outside
world, while projections from other limbic structures and the hypothalamus allow the amygdala
to process the body’s current emotional and physiological condition. Outputs from the amygdala
utilize these inputs to tell other structures how to respond. Outputs for emotional responses are
sent to the hypothalamus, brainstem, and ventral striatum. Outputs for emotional memories and
storage are sent back through the limbic system and hypothalamus, while outputs involving
heightened awareness are sent to sensory cortices (Vanderah & Nolte, 2018).
Normal activation of the amygdala results in attentive fear. We typically stop what we are
doing in a frozen state, become very in-tune to our surroundings, and then experience aggression
with either fight or flight responses via our sympathetic nervous system. Activation of the
sympathetic nervous system results in responses such as increased heart rate, pupil dilation, and
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blood vessel dilation in the muscles. These primal responses allow us to react to a perceived
threat, increasing our odds in survival. Since the amygdala sends projections to the hippocampus,
situations that heavily activate the amygdala will tell the hippocampus to store memories of the
events in order to remember next time a similar situation arises. Ratliff et al. (2019) found
significant neurostructural changes to the basolateral amygdala during research studies on rats
sustaining blast related TBIs (Ratliff et al., 2019). By mimicking the blast explosions as those
found overseas in combat zones, the researchers were able to expose rats to these blasts to
determine the traumatic effects on the amygdala. The researchers found a significant increase in
the number of dendritic branching, dendritic spine densities, and increased signaling within the
amygdala. The researchers hypothesized that the increased signaling within the amygdala can be
attributed to increased feelings of fear and hyperarousal, which can overtime lead to the
development of PTSD (Ratliff et al., 2019).
The hippocampus is another limbic structure which is extremely important to traumatic
events and how we as humans process our responses to the situation. The hippocampus is a
structure found in the medial aspect of the anterior temporal lobe which resembles a seahorse
shape (Felten & Shetty, 2011). The functional aspect of the hippocampus is memory formation,
specifically consolidating short-term memories into long-term storage. The hippocampus
contains a wide range of connections throughout the brain and within itself, with information
going to regions of the neocortex, temporal lobe and additional limbic structures such as the
amygdala (Felten & Shetty, 2011). Memory formation and storage involves explicit memory,
which are memories involving objects, stimuli, and information that is easily recalled and known
(Felten & Shetty, 2011). This includes information on specific personal events, dates, and facts.
Implicit memories, the ability to learn how to do tasks or skills unconsciously, are not dependent

13

on the hippocampus and rely on other surrounding brain structures. Storage of explicit memories
are dependent on the hippocampus and other structures in the medial temporal lobe. Within the
hippocampus are CA1 neurons containing pyramidal cells (Felten & Shetty, 2011). These
hippocampal cells are vulnerable to damage and apoptosis which can lead to long-term cognitive,
learning, and memory problems. Damage to these structures can lead to memory consolidation
problems, affecting immediate and short-term memories, confusion, and disorientation (Felten &
Shetty, 2011). Aungst et al. (2014) found substantial neuronal cell loss in both the ipsilateral and
contralateral hippocampus in patients with repeated mTBIs. Additionally, they found a
significant increase in the number of activated microglial cells, potentially serving as both
neuroprotective and neurotoxic agents (Aungst et al., 2014). The neuronal cell loss and increased
microglial presence leads to deficits in hippocampal functioning and a disruption in the synaptic
transmission between cells, something commonly found in chronic neuroinflammation and
neurodegeneration. This will play a role in the next section in regard to certain
neurodegenerative diseases involving memory deficits.
Wright et. al (2017) demonstrated in their research that rats sustaining a blast-related
traumatic brain injury can lead to progressive neuronal damage and eventual neuronal loss. The
researchers linked their results from rats to soldiers sustaining TBIs while in combat. They
hypothesized that a TBI can lead to progressive atrophy of the motor cortices with degeneration
of the corticospinal tracts (Wright et al., 2017). Wright et al. (2017) also found a reduction in
neurons with increased TDP-43 in the motor cortex, reduced spinal cord motor neurons, and
increased expression of muscle atrophy markers. The atrophy of the motor cortex due to reduced
neurons and pathologic TDP-43 is important because it leaves the brain susceptible for
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progressive neurodegenerative diseases such as Alzheimer’s Disease, ALS, CTE, and FTLD.
Specific neurodegenerative diseases will be discussed in the section below.
Progressive Neurodegenerative Diseases
Traumatic brain injuries, whether mild, moderate, or severe, can result in a complete
disruption in the normal processing of brain structures. Through repeated TBI exposures or
increased severity, these brain injuries can lead to progressive pathophysiological presentations
which include neuronal apoptosis, oxidative stress, neuroinflammation, diffuse axonal injuries,
and excitotoxicity (Blennow et al., 2012). This is extremely concerning for those individuals
serving within the United States military who are constantly at risk for TBI exposure, especially
blast-related, while overseas. These individuals are at a high risk for sustaining a TBI, which puts
them at an even higher risk for developing or triggering neurodegenerative diseases and PTSD
(Omalu et al., 2011). McKee and Robinson (2014) found evidence in their studies that even a
single TBI can lead to long-term gray and white matter atrophy, accelerate any present
neurodegeneration, and can increase the risk of Alzheimer’s Disease, Parkinson’s Disease,
Chronic Traumatic Encephalopathy, and motor neuron diseases such as ALS. They additionally
found that those individuals sustaining a moderate to severe TBI were at a 50% increased risk for
developing dementia-related diseases (McKee & Robinson, 2014). Due to these increased risks,
TBIs, especially moderate and severe, have become an extremely important risk factors for
progressive neurodegenerative diseases (Shahim et al., 2020). The connections between TBIs
and the mechanisms in which contribute to neurodegenerative diseases will be discussed below.
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Alzheimer’s Disease
Researchers have determined that TBIs are one of many risk factors for late-life
dementias, including Alzheimer’s Disease (AD) (Mortimer et al., 1991). The relationship
between this type of head trauma and Alzheimer’s Disease has been established, yet it is very
difficult for physicians to determine without looking at the neuropathology of the patient
(Daneshvar et al., 2011). There is however a correlation with veterans having a history of
traumatic brain injuries and higher prevalence of Alzheimer’s-disease pathology (Danesvhar et
al., 2011). The pathology of Alzheimer’s Disease within veterans diagnosed with TBIs are
similar to civilian patients with the AD diagnosis. There is a presence of amyloid-ß neuritic
plaques and phosphorylated-tau (p-tau) neurofibrillary tangles (NFTs) (McKee et al., 2013).
These amyloid-ß proteins are formed from amyloid-precursor proteins by ß-secretase and gamma
secretase (Blennow et al., 2012). Amyloid-precursor protein has been found to be upregulated as
a response to traumatic brain injuries, which in turn accumulate around the neurons and axons in
the brain as a result of the axonal damage (Blennow et al., 2012).
Parkinson’s Disease
Parkinson’s Disease is another progressive neurodegenerative disease that has been
connected to higher prevalence due to a history of traumatic brain injuries. Bower et al (2003)
determined that the association between traumatic brain injuries and development of Parkinson’s
Disease varies by the severity of TBI sustained. There is a similar but different neuropathology
to Alzheimer’s Disease with instead a presence of alpha-synuclein-positive Lewy bodies within
the brainstem (McKee et al., 2013). These alpha-synuclein proteins are the primary building
blocks of Lewy bodies, and accumulate as a response from the axonal damage from traumatic
brain injuries.
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Frontotemporal Lobar Degeneration
Frontotemporal Lobar Degeneration (FTLD) is a progressive neurodegenerative disease
characteristic of atrophy of the frontal and temporal lobes in the brain, that can lead to a type of
dementia called frontotemporal dementia (Heyburn et al., 2019). Frontotemporal dementia
(FTD) is one of the most common types of dementia found in individuals under the age of 65 and
has an even higher occurrence within the veteran community (Heyburn et al., 2019). Three types
of FTD exist including behavior, non-fluent, and semantic. FTD-Behavior involves behavior
changes such as disinhibition, apathy, and impulsivity. FTD-Non-Fluent involves difficulty in
speech production, while FTD-Semantic involves impaired speech comprehension (Heyburn et
al., 2019). Those veteran patients with a history of TBIs were 3.33 times more likely to develop
FTD and had earlier ages of onset for symptoms compared to patients with no previous TBI
diagnoses (Heyburn et al., 2013). The neuropathology of FTLD involves an accumulation of
phosphorylated-tau (p-tau) and TDP-43, a DNA and RNA binding protein that controls the
expression of many different types of genes (McKee et al., 2013). The TDP-43 proteins become
hyperphosphorylated and ubiquitinated, breaking off into pathological fragments that accumulate
in the cytoplasm. Studies have shown that in as little as one sustained TBI, accumulation of the
TDP-43 fragments can occur leading to significant changes in cognition and behavior (Heyburn
et al., 2019).
Chronic Traumatic Encephalopathy
Chronic Traumatic Encephalopathy (CTE) is a progressive neurodegenerative disease
that is characterized by widespread accumulation of hyperphosphorylated-tau (p-tau) as
neurofibrillary tangles (NFTs), typically caused by single, episodic, or repetitive trauma to the
head (McKee et al., 2013; Omalu et al., 2011). CTE is marked by structural changes within the
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brain such as atrophy of the cerebral cortex, medial temporal lobe, thalamus, and hypothalamus
(McKee & Robinson, 2014). In addition to widespread atrophy, there is enlargement of the
lateral and third ventricles and thinning of the corpus callosum and septum pellucidum (McKee
& Robinson, 2014). Structural changes within the limbic system such as damage to the
hippocampus, medial temporal lobe, and fornix, lead to behavioral changes, executive
dysfunction, memory loss, and other cognitive impairments (McKee & Robinson, 2014). These
behavioral and cognitive changes typically will begin insidiously but will progress over years
and have detrimental effects. There are currently four symptom stages of CTE that range from
headaches and loss of attention (Stage I) to more severe symptoms such as executive dysfunction
(Stage III) and dementia (Stage IV) (McKee et al., 2013). Researchers have shown that
symptoms typically will be present 8-10 years after sustaining a TBI (McKee & Robinson,
2014). Repetitive TBIs can increase the development of the disease, with researchers finding
cases of CTE in veterans of the Iraq and Afghanistan conflicts who had been exposed to
explosive blasts (McKee & Robinson, 2014). Neuropathological studies of postmortem brains
from veterans with a history of TBIs and blast exposures showed CTE that was consistent with
NFL athlete CTE case studies, further demonstrating the link between TBIs and this progressive
neurodegenerative disease. (Goldstein et al., 2012).
Cognitive Behavioral Changes
The effects of traumatic brain injuries within the veteran community go beyond the
structural and neuronal damages that occur. When neurological structures in the brain are
damaged, upstream and downstream pathways become disrupted leading to a wide range of
cognitive and behavioral changes. Structural damage and neuronal loss around the inferior
temporal lobe, nucleus basalis, septal nuclei, and amygdala has been shown to lead to irritability,
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impulsivity, explosivity, and increased aggression (McKee et al., 2013). Others have selfreported poorly controlled anger, social isolation issues, attention difficulty, poor concentration,
paranoia, insomnia, and depression (McKee & Robinson, 2014). Structural damage to the
subcallosal and inferior orbital frontal cortex and brainstem has been shown to lead to
depression, mood lability, headaches, and suicidality (McKee & Robinson, 2014; McKee et al.,
2013). As mentioned above, damage to the limbic structures results in numerous impairments in
learning and memory such as amnesia, mental confusion, and speech hesitancy. These behavioral
and cognitive changes, executive dysfunction, and memory loss are all characteristic to patients
who have sustained traumatic brain injuries.
Polytrauma Clinical Triad
The Polytrauma Clinical Triad was developed as a way to categorize the co-occurrences
of chronic pain, Post-Traumatic Stress Disorder (PTSD), and TBIs within the veteran community
(Blakey et al., 2018). These three co-occurrences have been associated with suicidal ideation,
violent impulses, increased pain intensity, drug abuse, and Major Depressive Disorder (Blakey et
al., 2018). Since the War on Terror began in 2001, suicide and self-harm has become an
increasingly major issue and concern among the veteran community. In a 2010 report by the
Department of Defense, suicide rates in all the service branches increased from roughly 10 per
100,000 people in 2001 to 20 per 100,000 people in 2010 (U.S. Department of Defense, 2010).
These rates continue to increase as veterans are increasingly exposed to the dangers of war and
blast exposures.
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition categorizes
Post-Traumatic Stress Disorder (PTSD) as a trauma-and-stressor-related disorder that comes as a
result from exposure to a traumatic or stressful event (American Psychiatric Association, 2013).
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The diagnostic criterion for PTSD is shown in Table 3, which shows the criteria for adults,
adolescents, and children over the age of 6. Within the veteran community, diagnosis for PTSD
results from the initial exposure to the traumatic events of combat and subsequent symptoms
within 6 months according to the ICD-10 (Substance Abuse and Mental Health Services
Administration, 2014). PTSD is characterized by frontal lobe dysfunction, executive dysfunction,
impulsivity, emotional lability, disinhibition, and impairments in attention and memory,
specifically working memory (Vasterling et al., 2009). These presiding symptoms come as a
result of damage to key structures within the brain including the prefrontal cortex, amygdala,
hippocampus, and white matter damage within the fronto-striatal fibers, fronto-limbic circuits,
fronto-parieto-occipital fibers, brainstem fibers, and callosal fibers (Elder et al., 2010; Yeh et al.,
2014). Sustaining a traumatic brain injury can damage these functional structures and further
increase the risk for development of PTSD symptoms, especially within the veteran community
(Elder et al., 2010). In addition to structural damage, PTSD has been found to be associated with
high white matter integrity within the bilateral anterior thalamic radiations, cingulum, and
frontotemporal tracts (Davenport et al., 2015).
Post-Traumatic Stress Disorder (PTSD) has been shown to be associated with TBIs and
suicide risks within the veteran community (Hoge et al., 2008). Loignon et al. (2020) has found
that the combination of combat military settings overseas and TBI diagnoses present far greater
risks for developing PTSD in veteran soldiers. They found that sustaining a traumatic brain
injury can lead to an initial PTSD diagnosis, severe PTSD symptoms compared to non-TBI
veterans, and a longer PTSD remission, with a roughly 16% lifetime prevalence in the military
community (Gates et al., 2012; Loignon et al., 2020). This increased risk is due to the overlap of
physiological and psychological symptoms from both TBIs and PTSD. Both TBIs and PTSD
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have been shown to be associated with neuropsychological impairments, ranging from problems
with attention, learning, memory, and executive function (Vasterling et al., 2009). Unlike TBIrelated impairments that can show up shortly after the traumatic event, PTSD symptoms take a
slower approach that can last years longer than TBI symptoms (Vasterling et al., 2009).
However, the context and location in which the traumatic brain injury was sustained is thought to
be determinant of how PTSD develops and progresses within an individual (Vasterling et al.,
2009). The neuropsychological processes that occur immediately after sustaining a TBI affects
the progressive development of PTSD. Within 24 hours after sustaining a TBI, there is an
emotional response formed to the traumatic event and short-term consolidation of memories,
including trauma memory (Vasterling et al., 2009). Fear conditioning also occurs, activating
certain biological pathways in response to stress, such as the HPA axis, autonomic nervous
system, cell-mediated immunity, and sleep/wake cycles (Bryant, 2001). These consolidated
traumatic memories and emotional responses are then later resurfaced due to certain triggers or
events as PTSD progresses in an individual.
Hoge et al. (2008) found a 44% prevalence in PTSD symptoms in 2525 soldiers who
screened positive for sustaining an mTBI, further suggesting the strong association between
mTBI and PTSD. In another study looking at veterans from Operation Iraqi Freedom, Operation
Enduring Freedom, and Operation New Dawn, 80% of soldiers exposed to a blast-related TBI
with early symptoms of CTE were also diagnosed with PTSD (McKee & Robinson, 2014).
These types of combat injuries play an increased role in PTSD and long-term health effects
including cardiovascular diseases and neurological disorders (Schneiderman et al., 2008). With
the association between TBI and PTSD, it is however clinically difficult to determine whether
the presenting symptoms are a result of sustaining a TBI or just PTSD (Stein & McAllister,
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2009). When looking at TBI and PTSD, one can view each as the opposite end of a spectrum. On
the TBI end, there is organic brain disease and structurally damaged areas of the brain, while on
the PTSD end there is psychologically reactive damage (Elder et al., 2010). Table 4 displays the
differences among PTSD and TBI symptoms. While each end of the spectrum may have their
own differences, the middle of the spectrum allows for heavy overlap in physiological and
psychological symptoms. These overlapping changes in the brain can lead to disrupted neural
connections and pathways that can present with behavioral and cognitive dysfunction. Research
is still evolving, although there is recent evidence that TBIs are more highly associated with
PTSD than any other type of injury sustained in combat (Hoge et al., 2008).

Table 3.

ICD-10 Diagnostic Criteria for Post-Traumatic Stress Disorder (PTSD) (adapted)
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Figure 1.

Relationship between PTSD and TBI (adapted from Stein & McAllister, 2009)
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RESEARCH STRATEGIES
Literature Review
A literature review was completed in order to describe and detail the complexities behind
traumatic brain injuries and their role in physiological and psychological changes within U.S.
combat veterans. Two major TBI databases were used to collect information on combat veterans
who have served during Operation Iraqi Freedom (OIF), Operation Enduring Freedom (OEF),
and Operation New Dawn (OND). The Comprehensive Traumatic Brain Injury Evaluation
(CTBIE) database includes combat veterans who have served in the Iraq and Afghanistan,
separated from the military, enrolled in the VHA healthcare system, and received a
comprehensive TBI evaluation. The National Patient Care Database (NPCD) includes other
combat veterans enrolled in the VHA healthcare system who have received inpatient or
outpatient TBI diagnoses as part of routine clinical care. Definitions and criteria for the
psychological disorders mentioned in this paper were taken from the Diagnostic and Statistical
Manual of Mental Disorders, 5th Edition (DSM-5) and the International Statistical Classification
of Diseases and Related Health Problems, 10th Edition (ICD-10).
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DISCUSSION
Treatment/Management
The awareness for treatment of traumatic brain injuries has drastically increased over the
years. Dedicated research centers and rehabilitation centers for both military veterans and
civilians have popped up across the United States. In order for treatments to be effective,
researchers and healthcare workers need to understand the structural and neuronal damages and
changes that the brain endures after sustaining a TBI (McKee & Robinson, 2014). The
psychological effects need to equally be addressed as well, as research has shown the link
between TBI and cognitive changes such as PTSD. By addressing the brain injuries and
psychological stress, healthcare teams can efficiently treat and manage their patients’ symptoms
both short-term and long-term prognoses (Srinivasan et al., 2019). Rosenfeld et al. (2013)
suggests the evidence-based clinical practice model to manage mTBI symptoms. They
recommend a multidisciplinary team approach, using extensive rehabilitation programs,
cognitive rehabilitation, ophthalmological assessments, periodic neuroimaging to manage the
progression, and posture and gait assessments, and retraining if the soldiers need it (Rosenfeld et
al., 2013). The benefit to a multidisciplinary approach allows for complete management of
symptoms and to watch for any neurodegeneration. The quicker the team can determine if any
neurodegenerative disease is present, the sooner they can begin treatments to help prevent further
damage or disease progression.
Fluorodeoxyglucose-positron emission tomography (FDG-PET) has become useful in
research studies by Peskind et al (2011). FDG-PET imaging allows researchers to measure
certain neurobiological substrates that are associated with repeated blast-related mTBIs. The
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associated neurobiological substrates can signify certain somatic, cognitive, and behavioral
symptoms that are commonly reported by veterans from the Iraq and Afghanistan conflicts. The
ability to track and measure neurobiological substrates via the FDG-PET imaging can play a
significant role in diagnosis and treatment. The ability to use imaging tools in help diagnose and
treat TBI patients will drastically improve care in addition to what is already deemed standard
care. Healthcare teams typically use several factors such as injury severity, the initial GCS given
in the field, age, medical comorbidities, and any associated injuries to establish a plan of care. As
treatment progresses, they will monitor the patient’s response to therapy and adjust the protocols
based upon the type of TBI sustained, either global or focal injury (Srinivasan et al., 2019).
The ability to test for neuro-biomarkers will significantly improve the approach to
diagnosing TBIs and the associated treatment plans. Not only will treatments improve, but
healthcare teams will also be able to assess and monitor the progression of the injury in real time,
adjusting care as needed. Currently, there are no objective biomarkers that can pinpoint exact
symptoms and injury progression, yet researchers have begun to focus on a few biomarkers that
have been consistently associated with traumatic brain injuries and neuronal damage: GFAP,
NfL, S-100ß, tau, MBP, and UCH-L1. GFAP, otherwise known as glial fibrillary acidic protein,
is an intermediate filament protein expressed by astrocytes in the central nervous system that
typically marks the mechanical strength of cells (Okonkwo et al., 2013). Researchers have
hypothesized that when there is astrocyte brain damage due to a TBI, GFAP is able to cross the
disrupted blood-brain barrier and become detected in the peripheral blood. Okonkow et al.
(2013) found an association between the levels of plasma GFAP and the Glasgow Coma Scale
scores. The serum levels of GFAP increased as the GCS scores decreased, and these elevated
levels were consistently found in subacute and chronic TBI cases (Shahim et al., 2020). In
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addition, Yue et al. (2019) found that the plasma levels of GFAP in patients after sustaining a
TBI correlated with the intracranial injury shown on CT scans. The researchers concluded that
GFAP would be a great diagnostic tool to help early detection of TBI and determine whether
more imaging is necessary for each patient. UCH-L1, otherwise known as ubiquitin C-terminal
hydrolase L1, is a degradation enzyme expressed specifically by neurons in the brain. UCH-L1 is
able to cross the disrupted blood-brain barrier when there is neuronal damage after a sustained
TBI. Researchers have found elevated blood levels of UCH-L1 during the acute phase of a TBI
as well as in severe TBI cases (Shahim et al., 2020; Yue et al., 2019). Tau is a protein associated
with the structural stability of microtubules of unmyelinated axons in the central nervous system.
Similar to UCH-L1 and GFAP, tau is able to cross the disrupted blood-brain barrier as a result of
neuronal damage caused by a TBI. Although Shahim et al. (2020) found elevated blood levels of
tau in patients with a TBI, there was no significant correlation to severity, outcome, or imaging.
Since tau is associated with neurodegenerative diseases, the researchers concluded that the
accumulation of tau as a result of a TBI can contribute to the progression of those diseases.
While UCH-L1 and GFAP have been shown to be useful diagnostic biomarkers, NfL has
become an increasingly popular and more effective diagnostic marker. NfL, otherwise known as
neurofilament light chain protein, is a structural component of the cytoskeletons of axons. NfL is
typically expressed in large myelinated subcortical axons, which are vulnerable to breakdown
during a TBI event (Shahim et al., 2020). Damage to the cytoskeleton of these subcortical axons
allows NfL to become detected in the peripheral blood, crossing the disrupted blood-brain barrier
like GFAP and UCH-L1. Shahim et al. (2020) found that blood levels of NfL can help healthcare
teams determine the severity of the TBI, whether mild, moderate or severe, and can help serve as
control levels to compare months and years post-injury.
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RECOMMENDATIONS FOR FUTURE STUDIES

As mentioned in the Discussion, the continued research into biomarkers that can help
identify and target treatments for soldiers diagnosed with a TBI is crucial. The more biomarkers
and the more information we have about what they mean cellularly and physiologically can help
rehabilitation programs individualize their programs and the soldier’s needs. These neurobiomarkers can dramatically help in the initial assessments of TBI, becoming a diagnostic tool to
help confirm any abnormalities in neuroimaging and head CT scans (Yue et al., 2019). The fact
that a simple blood test can tell a wealth of knowledge can hopefully be implemented in the
future to combat zones. Combat medics overseas would be able to test right then and there in the
field, and quickly diagnose and provide first-line treatment rather than have time pass to truly
diagnose a TBI. In addition to serum biomarkers, future studies must look into specific
rehabilitation treatments to aid in a more complete and increased recovery. Such protocols
should include restorative practices that focus on the mechanisms that help promote and build
neuroplasticity like addressing sleep needs, exercise, and nutrition (McKee & Robinson, 2014).
Pharmacological agents should be researched and trialed to help reduce any cognitive deficits in
solders sustaining a TBI, especially soldiers who are constantly suffering from PTSD and
suicidal tendencies. These therapeutic agents should take a holistic approach to treating the
soldiers, providing care for the structural damages from the TBI itself and also the invisible
cognitive wounds that may appear months to years later.
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